Deaths by HIV disease in the U.S. 1990-2017
HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was 16.2. That number has since decreased to 1.6 per 100,000 as of 2017. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications.
HIV/AIDS in the U.S.
Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body is no longer able to fight off infections. The number of AIDS diagnoses in the U.S. has decreased significantly in recent years. Among all U.S. states, Georgia, followed by Florida, had the highest rates of new HIV diagnoses in 2017.
HIV/AIDS treatments in the U.S.
HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the Ryan White Program and the National Institutes of health (NIH). The top HIV drug worldwide, based on revenue generated as of 2018 was Genovoya. Around the world access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.
HIV/AIDS in the U.S.
Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body is no longer able to fight off infections. The number of AIDS diagnoses in the U.S. has decreased significantly in recent years. Among all U.S. states, Georgia, followed by Florida, had the highest rates of new HIV diagnoses in 2017.
HIV/AIDS treatments in the U.S.
HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the Ryan White Program and the National Institutes of health (NIH). The top HIV drug worldwide, based on revenue generated as of 2018 was Genovoya. Around the world access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.
